Revolution Medicine, Novartis, Anthropic: Readout Newsletter
Wish to keep on prime of the science and politics driving biotech at the moment? Join to get our biotech e-newsletter in ...
Tag: Novartis
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug
Merck has been buying belongings that might assist make up for the approaching income decline as its high product, the ...
Estate of Henrietta Lacks settles with Novartis over immortal cells
Novartis has settled a lawsuit by the property of Henrietta Lacks that alleged the pharmaceutical large unjustly profited off her ...
Novartis to acquire RNA-focused Avidity Biosciences for $12B
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Novartis, Regeneron, J&J, cancer research
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Viz.ai, Novartis partner for AI-powered care for patients with cancer
Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!